Want to join the conversation?
$AMGN stated that the Neulasta Onpro kit achieved 24% share of all Neulasta sales in 4Q15. QoverQ Neulasta was negatively impacted by the burn-off of some larger US custom purchases in 3Q15. The company expects Neulasta to grow modestly in 2016, as it does not expect a biosimilar launch in the US until the end of the year at the earliest.
Of all the Wall St firms out there, Goldman Sachs $GS is the most revered for the way they're run - hiring the best, highly competitive, a closely-knit peer group and making tons of profits for the shareholders. An interesting interview of its CEO Llyod Blankfein by Carlyle groups chief David Rubenstein
Great results from $TSLA, however the question remains if Tesla can continue to scale up to produce the cars in the quantity it promises. Model 3 numbers need to be in multiples of what they are producing right now. Wish them the best, will keep an eye as I am still not convinced that they can scale easily.
Watching $TSLA Oct 28th $215 Calls for possible entry
Chipotle stock is crashing like a falling knife after it's earnings report last evening; down about 10% already today! Was Bill Ackman wrong in buying about 10% stake in $CMG couple of months ago? Or is this market reacting to disappointing earnings? And can they really get customers to trust them again after food-safety crisis?